|
Volumn 31, Issue 5, 2012, Pages 248-256
|
YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
INDAZOLE DERIVATIVE;
LIFICIGUAT;
MESSENGER RNA;
OXYGEN;
STAT3 PROTEIN;
ANIMAL;
APOPTOSIS;
ARTICLE;
BAGG ALBINO MOUSE;
BREAST TUMOR;
CANCER TRANSPLANTATION;
CELL CYCLE;
CELL CYCLE G1 PHASE;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
GENETICS;
HUMAN;
METABOLISM;
METASTASIS;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
TUMOR CELL LINE;
TUMOR VOLUME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BREAST NEOPLASMS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
FEMALE;
G1 PHASE;
HUMANS;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
INDAZOLES;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM METASTASIS;
NEOPLASM TRANSPLANTATION;
OXYGEN;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RNA, MESSENGER;
STAT3 TRANSCRIPTION FACTOR;
TUMOR BURDEN;
|
EID: 84872768240
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: 10.5732/cjc.011.10383 Document Type: Article |
Times cited : (17)
|
References (0)
|